NCT00081510View on ClinicalTrials.gov

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

Lonafarnib

DRUG

Placebo

DRUG

anastrozole

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00081510 - Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480) | Biotech Hunter | Biotech Hunter